Target Information

Content Navigation (  All   None )                                      
Target General Information
Drugs and Modes of Action
Drug Binding Sites of Target
Different Human System Profiles of Target
Target Affiliated Biological Pathways
References
Drug Binding Sites of Target  Top
Ligand Name: Cyanocobalamin Ligand Info
Structure Description NMR solution structure of vitamin B12 conjugates of PYY3-36 PDB:2NA5
Method Solution NMR Resolution N.A. Mutation No [3]
PDB Sequence
IPEAPGEDAS
14
PEELNRYYAS
24
LRHYLNLVTR
34
QRY
Residue
Distance (Å)
ALA8
2.407
PRO9
2.468
GLY10
2.580
ALA13
4.560
SER14
2.012
Residue
Distance (Å)
GLU17
3.511
LEU18
2.886
TYR21
2.871
TYR22
4.255
Ligand Name: 6-[4-(2-aminoethyl)-1H-1,2,3-triazol-1-yl]-L-norleucine Ligand Info
Structure Description NMR solution structure of vitamin B12 conjugates of PYY3-36 PDB:2NA5
Method Solution NMR Resolution N.A. Mutation No [3]
PDB Sequence
IPEAPGEDAS
14
PEELNRYYAS
24
LRHYLNLVTR
34
QRY
Residue
Distance (Å)
ILE3
1.338
PRO6
1.344
GLU7
4.617
Residue
Distance (Å)
ALA8
4.303
TYR21
4.014
TYR28
3.724
Click to View More Binding Site Information of This Target with Different Ligands
Different Human System Profiles of Target  Top
Human Similarity Proteins of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs (Brief Bioinform, 21: 649-662, 2020).
Human Pathway Affiliation of target is determined by the life-essential pathways provided on KEGG database. The target-affiliated pathways were defined based on the following two criteria (a) the pathways of the studied target should be life-essential for both healthy individuals and patients, and (b) the studied target should occupy an upstream position in the pathways and therefore had the ability to regulate biological function.
Targets involved in a fewer pathways have greater likelihood to be successfully developed, while those associated with more human pathways increase the chance of undesirable interferences with other human processes (Pharmacol Rev, 58: 259-279, 2006).
Biological Network Descriptors of target is determined based on a human protein-protein interactions (PPI) network consisting of 9,309 proteins and 52,713 PPIs, which were with a high confidence score of ≥ 0.95 collected from STRING database.
The network properties of targets based on protein-protein interactions (PPIs) have been widely adopted for the assessment of target’s druggability. Proteins with high node degree tend to have a high impact on network function through multiple interactions, while proteins with high betweenness centrality are regarded to be central for communication in interaction networks and regulate the flow of signaling information (Front Pharmacol, 9, 1245, 2018; Curr Opin Struct Biol. 44:134-142, 2017).
Human Similarity Proteins
Human Pathway Affiliation
Biological Network Descriptors
Protein Name Pfam ID Percentage of Identity (%) E value
Putative peptide YY-2 (PYY2) 86.667 (26/30) 1.89E-10
 Download Picture         KEGG Link      
KEGG Pathway Pathway ID Affiliated Target Pathway Map
Neuroactive ligand-receptor interaction hsa04080 Affiliated Target
  Class: Environmental Information Processing => Signaling molecules and interaction Pathway Hierarchy
Degree 2 Degree centrality 2.15E-04 Betweenness centrality 1.15E-08
Closeness centrality 1.36E-01 Radiality 1.14E+01 Clustering coefficient 0.00E+00
Neighborhood connectivity 2.00E+00 Topological coefficient 1.00E+00 Eccentricity 14
Download Click to Download the Full PPI Network of This Target

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.